APPLIED THERAPEUTICS
2.0300
29-November-24 13:45:00
15 minutes delayed
Stocks
-6.5400
-76.31%
Today's range
2.0300 - 2.4400
ISIN
N/A
Source
NASDAQ
-
28 Sep 2023 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports Second Quarter 2023 Financial Results
10 Aug 2023 07:00:44 By Nasdaq GlobeNewswire
-
22 Jun 2023 07:00:00 By Nasdaq GlobeNewswire
-
15 Jun 2023 07:00:00 By Nasdaq GlobeNewswire
-
25 May 2023 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports First Quarter 2023 Financial Results
11 May 2023 07:00:35 By Nasdaq GlobeNewswire
-
Applied Therapeutics, Inc. Announces $30 Million Private Placement of Equity
24 Apr 2023 07:00:00 By Nasdaq GlobeNewswire
-
24 Apr 2023 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports Fourth Quarter and Year-end 2022 Financial Results
23 Mar 2023 06:30:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics to Present at the Cowen 43rd Annual Health Care Conference
01 Mar 2023 07:00:01 By Nasdaq GlobeNewswire
-
16 Feb 2023 07:00:01 By Nasdaq GlobeNewswire
-
Applied Therapeutics to Present at the SVB Securities Global Biopharma Conference
09 Feb 2023 07:00:00 By Nasdaq GlobeNewswire
-
04 Jan 2023 06:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports Third Quarter 2022 Financial Results
09 Nov 2022 07:00:02 By Nasdaq GlobeNewswire
-
31 Oct 2022 07:00:00 By Nasdaq GlobeNewswire
-
25 Oct 2022 07:00:01 By Nasdaq GlobeNewswire
-
06 Oct 2022 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports Second Quarter 2022 Financial Results
12 Aug 2022 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics to Sponsor and Present at the 2022 Galactosemia Foundation Conference
28 Jul 2022 07:00:01 By Nasdaq GlobeNewswire